Currently Viewing:
ACO & Emerging Healthcare Delivery Coalition® Spring 2017
Dr Mark Friedberg: How Practices Shifting to Value-Based Care Models Can Alleviate Burnout
November 16, 2017
Dr Frank James on the Role of Stigma in Addiction Treatment
November 15, 2017
Dr Darius Lakdawalla Discusses the Meaning and Measure of "Value" in Healthcare
September 13, 2017
Dr Darius Lakdawalla on the Willingness to Pay for a Cure
August 02, 2017
Dr Clifford Goodman: A Look at the Present and Future of Value Frameworks
July 22, 2017
Michael Griffin Describes Daughters of Charity's Long History of Leadership
July 21, 2017
Dr Sachin Jain Discusses CareMore's Community Partnerships, Internal Programs
July 18, 2017
Lee Barrett Outlines Best Practices for Healthcare Cybersecurity
July 15, 2017
Michael Griffin on Aligning Payers With Population Health and Social Determinants
July 12, 2017
Dr Clifford Goodman on Possible Drug Pricing Solutions Adapted From Abroad
July 11, 2017
Dr Sachin Jain on CareMore's Mission to Manage Chronic Disease From the Dentist's Chair
July 08, 2017
Michael Griffin Discusses Daughters of Charity's Ongoing Technology Initiatives
July 03, 2017
Lee Barrett: Increased Data Exchange in Value-Based Models Poses Cybersecurity Risks
June 29, 2017
Michael Griffin: Katrina's Lasting Effects on New Orleans and Its Healthcare System
June 22, 2017
Dr Clifford Goodman Discusses Evidence-Based Drug Pricing as an Alternative to Legislative Controls
June 21, 2017
Dr Sachin Jain Focuses on Bipartisan Healthcare Efforts, Not Policy Changes
June 15, 2017
Lee Barrett on the Balance Between Strong Cybersecurity and Patient Access to Data
June 13, 2017
Dr Clifford Goodman on What to Look Forward to at the Fall 2017 ACO Coalition Meeting
June 09, 2017
Dr Sachin Jain: Discussion on Population Health Reveals Causes for Optimism
June 01, 2017
Currently Reading
Dr Clifford Goodman: Why Focus on Value Will Persist Regardless of Changing Legislation
May 29, 2017

Dr Clifford Goodman: Why Focus on Value Will Persist Regardless of Changing Legislation

Amidst a turbulent political climate as Republicans endeavor to enact the American Health Care Act, the shift to value-based contracts will continue due to the other market forces in play, explained Clifford Goodman, PhD, moderator at the ACO Coalition spring live meeting in Scottsdale, Arizona, and senior vice president and director at the Center for Comparative Effectiveness Research at the Lewin Group.


Amidst a turbulent political climate as Republicans endeavor to enact the American Health Care Act (AHCA), the shift to value-based contracts will continue due to the other market forces in play, explained Clifford Goodman, PhD, moderator at the ACO Coalition spring live meeting in Scottsdale, Arizona, and senior vice president and director at the Center for Comparative Effectiveness Research at the Lewin Group.

Transcript (slightly modified)

Do you expect Republican legislation to repeal and replace the Affordable Care Act to impact value-based reimbursement, or will gains in this area continue on regardless of new legislation?

Notwithstanding the recent political changes, including the AHCA and its ability to repeal and/or replace the Affordable Care Act, value-based reimbursement is going to continue. There are too many other market forces in play with regard to concerns about high drug prices, concerns about high prices overall for a variety of healthcare services, and the need for and focus on value for beneficiaries of all of our payer groups, provider groups, employers, and so forth.

They’re all caring about value. So, notwithstanding the extent of coverage of our populations in the United States, notwithstanding issues such as co-payments, deductibles, patient burden, and so forth, there’s going to be a continued focus on value.

I must say that it is also fueled in great measure by the continued innovation in the country. As long as we are helping to fund and provide incentives for innovation, there will be challenges about the trade-offs of benefits and costs for anyone making decisions about acquiring and accessing healthcare in the United States, so value-based contracting, outcomes-based contracting, so forth, I think will continue to evolve. That does not mean that it is a straight and narrow path to those, because in some instances it’s very difficult to implement those, but we will continue to make progress nonetheless.

 
Copyright AJMC 2006-2017 Clinical Care Targeted Communications Group, LLC. All Rights Reserved.
x
Welcome the the new and improved AJMC.com, the premier managed market network. Tell us about yourself so that we can serve you better.
Sign Up
×

Sign In

Not a member? Sign up now!